The prevalence of leukemia is increasing worldwide. Chronic Myeloid Leukemia (CML) patients benefit from recently improved care but receive prolonged,...
Dealing with multiple data sources:Fundamental aspects of data integration and reconciliation for high data qualityAs technology's penetration in the clinical...
Biotechs play a pivotal role in driving innovation, contributing significantly to the development of groundbreaking therapies for patients. But they...
At Kayentis, client satisfaction isn't just a goal—it's our standard. We pride ourselves on delivering services that embody responsiveness, reliability,...
Asthma clinical trials present several specificities, such as the use of disease-specific health-related quality of life instruments. Asthma clinical research...
NonAlcoholic SteatoHepatitis (NASH), now called Metabolic Dysfunction-Associated SteatoHepatitis (MASH), affects almost 115 million adults globally and is the most severe...
In contrast to paper solutions, electronic Clinical Outcome Assessment (eCOA) demonstrates strengths such as:AccuracyCompletenessTimingsAttributabilityUser-friendlinessRegulatory compliance Download the "eCOA vs paper"...
In a clinical trials environment that is moving increasingly towards digitalization and decentralization, it remains crucial to maintain high-quality electronic...
Why do customers recommend Kayentis for operational excellence? More than 95% of Kayentis customers recommend Kayentis for its:Customer-centric approachEnd-to-end project...
In the ever-evolving landscape of biotechnology, groundbreaking advancements continue to shape the future of healthcare. In this exclusive interview, Estelle...
In this episode, Ally Hochman, Clinical Operations Project Manager at Kayentis, offers valuable insights into enhancing technology adoption, establishing enduring...
What extra considerations are required for successfully implementing Decentralized Clinical Trials (DCTs) in addition to those for traditional site-based trials?...
Electronic devices have been systematically provided to participants to report Patient Reported Outcome (PRO) data in clinical trials and electronic...
Cultural differences and individual preferences have a significant impact on healthcare and clinical trial experience. Solutions exist in attempt to...
Despite the evolution in pediatric legislation and a renewed interest in developing therapeutics for pediatric and rare diseases, pediatric clinical...
Alliance merges products and services, gaining patients, sites and sponsors unique access to best-in-class eCOA, eConsent and patient engagement solutions.Single...
Basile Trimbur, Medical and Scientific Officer, Patient Engagement Lead at Kayentis, interviews Trishna Bharadia, Health Advocate & Patient Engagement Advisor,...
Date: October 18Location: PariSanté Campus in ParisOBJECTIVES:Define decentralized clinical trials, provide an update on their development and implementation in France...
Discover our 2021 employee satisfaction survey results! Strong employee satisfaction and well-being at Kayentis are key ingredients for growth, enthusiasm,...
Dedicated to improve patient experience in clinical trials, Kayentis’ Clin’form solution offers the flexibility to customize questionnaire design with illustrations...
With clinical trials digitalization and decentralization comes the possibility for patients to complete several of their clinical study procedures remotely,...
Improving patients’ experience using Kayentis unified platform and implementing robust technology integration.Visiting sites remotelyReceiving study information and supportProviding study experience...
Oncology studies present specific challenges that generate complex eCOA build and management: complex study design, frequent amendments, and long study...
We collaborate with patients to characterize their clinical trials expectations and better understand their readiness for remote clinical trials.This 11-question...
Many chronic diseases such as invasive cancers, inflammatory disorders, cardiovascular, or central nervous system diseases can have a significant impact...
The clinical trials industry has been facing numerous and long-lasting challenges of patient recruitment and retention, patient compliance, and clinical...
BYOD is a patient-centered method of collecting patients’ data electronically during clinical trials, providing strong value for pharma organizations and...
How can digital innovation turn clinical trials into a positive patient and site experience?
Digital innovation is increasingly penetrating the healthcare industry and technological advances create a new avenue for the optimization of clinical...
Although much progress has been made in developing scientific knowledge and conducting clinical research in rare diseases, serious challenges remain....
Press Release // Kayentis raises €7M ($8.3M) to accelerate the global expansion of its digital platform for clinical trials
Funds will strengthen Kayentis’ digitalization approach in transforming how pharma, investigator sites and patients engage in clinical trials Grenoble, France,...
Press Release // Kayentis forges ahead on five new eCOA service projects with emerging biopharma firms in Europe and US
Kayentis sets up incoming EBPs, major contributors in biomedical innovation, as well as its existing clients, with contingency plans to...
3 reasons for using tablet for clinical data collection @Home
Electronic capture of patient data is increasingly replacing the use of paper-based diaries, and electronic Clinical Outcomes Assessment (eCOA) tools...
Technological ways to make clinical trials really global
Although clinical trials are meant to cover global populations, the pool of patients currently enrolled in clinical trials is not...
https://youtu.be/cY5lYM_wBDQ PROs in ophthalmology trials can either be self-administered by the patient or the responses can be collected through an...
Key #3 for successful ePRO selection in your ophthalmology clinical trial: Get your patients involved
https://youtu.be/Cp7vd1fBKbc Although clinical research stakeholders strive to be patient-centered in their approach, dependence on clinical parameters alone is not enough....
Key #2 for successful ePRO selection in your ophthalmology clinical trial: Use your PROs to power economic evaluations
https://youtu.be/rH4yG-sxE9w Incorporating an economic evaluation within a trial provides valuable information for clinical decision making and coverage determinations, particularly when...
Misconception #5 on eCOA barriers: Regulatory bodies are reluctant to accept eCOA data
https://youtu.be/C1bRj8NwM7Y There seems to be a lot of uncertainty here as people tend to think that electronic data acceptance by...
Misconception #4 on eCOA barriers: Preparing for eCOA requires additional lead time
https://youtu.be/gmnVSwOoIiI Time is of the essence for any clinical study. Nobody wants to lose time when starting a clinical trial....
https://www.youtube.com/watch?v=eHQWWje4VwI&feature=youtu.be PROs have become a vital part of modern ophthalmology with an increasing focus on PROs within high-quality ophthalmic trials....
Misconception #3 on eCOA barriers: eCOA implementation requires higher investment
https://youtu.be/G_bGrZ6nXbk A general misconception is that eCOA implementation will generate additional costs. Early investment is required for eCOA implementation that...
Misconception #2 on eCOA barriers: Data might be lost due to device failure
https://youtu.be/vCsK9JI61-U The fear of losing data is more than legitimate. As clinical trial stakeholders you will have good stories to tell...
Misconception #1 on eCOA barriers: Patient training and re-training plan is a burden
https://youtu.be/y22gyfmBYsU As “end users “of innovative technologies, site staff and patients need to embrace the digital transformation as much as...
Are barriers to eCOA adoption true hurdles?
Over recent years, as an industry, we seem to have created a paradox: we increase investment in technological developments, but...
eCOA Back-up Solutions: Perception vs Reality
Digital solutions have without a doubt improved both the quality and the quantity of data collected in clinical trials. The...
Aware of its responsibility towards the environment, Kayentis decided to help financially two health-focused associations in Grenoble and Meylan. The...
Kayentis extends its contribution to scientific research in clinical trial endpoint assessment and joins the Critical Path Institute’s ePRO Consortium
25-year pharma industry veteran and clinical trials expert will strengthen Kayentis’ eCOA offering to sponsors seeking to use digital patient-facing...
Kayentis is committed to responsible waste management After the promotion of environmentally friendly transport - 2018 Sustainable Mobility Report - (e.g....
Implementing Kayentis Spirit in the US, a key challenge for Kayentis team
Interview with Björn Felber – Project Director, Kayentis US In June 2018, Kayentis was strengthening its presence in the US...
Challenges of back-up solutions in eCOA studies
Why is there a need for a back-up solution? In some cases, the eCOA user (investigator/site staff, patient, or observer)...
Moving together towards a better tomorrow At Kayentis, we recognize that we all play a part in ensuring each other’s...
Press release // OMRON Healthcare and Kayentis join forces to deliver an integrated and cost-efficient approach to remote monitoring of patients in clinical trials
We are proud to announce our collaborative work with OMRON Healthcare on the development of an integrated and cost-efficient approach...
Kayentis announces the release of its new eCOA solution, Clin’form3 Suite
A multi-platform eCOA solution to address the clinical trial needs of the future Over the last 2 years, Kayentis has...
Infography: Kayentis added values for CROs
Kayentis is a global eCOA vendor created in 2003, 100% dedicated to eCOA. Here is an overall infography about Kayentis...
Mobile technologies & wearable devices for Healthcare and Clinical Research
Mobile technology & wearable devices are becoming increasingly prominent in healthcare and clinical research, but we're only starting to understand...
// White paper // Digital Technology and Patients Tools in Clinical Trials – Part 2
Moving on from the “Selection & Evaluation of Technology Service Providers White Paper Part 1”, this white paper about digital...
Joining Kayentis: Values, mission and vision
Joining Kayentis means also joining a company with its own values, a real vision and a concrete mission. Beyond being...
// White paper // Digital Technology and Patients Tools in Clinical Trials – Part 1
Digital technology today has become an important tool in facilitating access to and engagement with the subjects participating in clinical...
// White paper // The European Union General Data Protection Regulations
The European Union (EU) Data Protection Regulations (GPDR), effective from 27 April 2016, will apply to all organisations responsible for data...
// Innovation by Kayentis // R&D moves into an ‘Agile’ mode of operation
How the Agile mode, implemented in Kayentis’ R&D department, improves the quality of solutions as well as client satisfaction. It’s...
What can eDiary bring to your study?
During a clinical trial, in particular for late phase trials, it becomes increasingly important to be able to collect a...
Accreditation by the French Ministry of Research
‘We are proud to announce that we have been accredited by the French Ministry of Research as an organisation that...
Infography: 7 lesser known advantages of eCOA over COA
Advantages of eCOA: Clinical Outcomes Assessment (COA) data in clinical and epidemiological studies can be collected using traditional paper questionnaires...
// White paper // Local storage or Cloud hosting?
Over the last 25 years the collection of clinical research data has moved from paper-based systems to electronic data capture...
Actigraphy devices: a real impact on clinical research?
Actigraphy has been used in clinical trials for almost 20 years. Recently their inclusion in study protocols has been increasing,...
Advantages of direct review of patient-recorded data by clinicians
In ePRO clinical trials, patients may use tablets to record their data. What if the clinician uses the same device...
//White paper// eCOA vs COA: pros and cons
Electronic tools allow the collection of data (electronic Clinical Outcomes Assessments [eCOA]) from patients, physicians, observers (mainly parents), and caregivers...
Hidden costs of paper ICFs
The past few years have seen a new breakthrough in electronic data capture: the electronic Informed Consent Form (eICF). Nowadays,...
Infography: planning an oncology study with eCOA/ePRO
The FDA has provided guidance on methodology to be used for developing and using PRO in oncology drug development programmes,...
The constant increase in the volume of clinical data and the emergence of new technologies in the medical field over...
Kayentis announces a breakthrough feature available in ePRO clinical trials: clinician review of data on a tablet device
It is essential that clinicians review PRO data. When patients complete questionnaires using a tablet, the use of different device...
eCOA solutions in oncology: What to consider when planning an oncology study with eCOA /ePRO?
The FDA has provided guidance on methodology to be used for developing and using PRO in oncology drug development programmes,...
//COAs white paper// Why are they important criteria in the evaluation of dossiers by health authorities?
Diverse elements have combined in recent years to make Clinical Outcome Assessments (COAs), and particularly Patient Reported Outcomes (PROs), important...
Kayentis goes one step further in the integration of electronic Informed Consent to improve patient convenience and sponsor efficiency
The announcement in May 2016 of the partnership between Kayentis and SecureConsent was just the first step in the integration...
Kayentis proud to publish the results of its customer satisfaction survey Conducted among more than 60 Kayentis clients, this investigation reveals that 90% of surveyed...
Kayentis closes 3.6 M€ growth financing round
Innovation Capital and Extens finance 3.6 M€ round to accelerate the international growth of Kayentis. Kayentis, a global provider of electronic...
KAYENTIS announces its participation in the Avoca Diligent Prequalification Platform
Choosing a provider in the clinical trials market is a costly and time-consuming process for sponsors and CROs. To better...
How to handle connectivity issues in electronic Clinical Outcome Assessment (COA) clinical studies?
Connectivity is key when using electronic Clinical Outcome Assessment (eCOA) tools in clinical studies. But what are the requirements of...
Key benefits of using a “Tablet device” for eCOA in Psoriasis studies
Psoriasis is a chronic immune-mediated inflammatory disease of the skin with various presentations and clinical courses. The commonly used measures...
How to choose an electronic Clinical Outcome Assessment (eCOA) backup solution?
In recent years the use of electronic Clinical Outcome Assessment (eCOA) tools to improve clinical data quality has become more...
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
